SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                ----------------

                                  SCHEDULE 13D
                                 (Rule 13d-101)

            INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13d-2(a)

                         (Amendment No. __________ )*


                          PACIFIC PREMIER BANCORP, INC.
--------------------------------------------------------------------------------
                                (Name of Issuer)


                     Common Stock, par value $0.01 per share
--------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    69478X105
--------------------------------------------------------------------------------
                                 (CUSIP Number)

                                   Ezri Namvar
                             New Life Holdings LLC
                             11940 San Vicente Blvd.
               Los Angeles, California 90049, Tel: (310) 207-1000
--------------------------------------------------------------------------------
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)


                                January 17, 2002
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of This Statement)

     If the filing  person has  previously  filed a statement on Schedule 13G to
report the  acquisition  that is the subject of this Schedule 13D, and is filing
this  schedule  because  of Rule  13d-1(e),  13d-1(f)  or  13d-1(g),  check  the
following box [_].


          Note:  Schedules filed in paper format shall include a signed original
     and five copies of the schedule, including all exhibits. See Rule 13d-7 for
     other parties to whom copies are to be sent.

----------
*    The  remainder  of this  cover  page  shall be filled  out for a  reporting
     person's  initial  filing on this form with respect to the subject class of
     securities,  and for any subsequent amendment containing  information which
     would alter disclosures provided in a prior cover page.

     The  information  required on the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 or otherwise  subject to the  liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                         (Continued on following pages)
                              (Page 1 of 12 Pages)




CUSIP No. 69478X105                    13D                    Page 2 of 12 Pages


--------------------------------------------------------------------------------
1    NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     New Life Holdings LLC
     FEIN: 96-4869333
--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a) [_] (b) [X]

--------------------------------------------------------------------------------
3    SEC USE ONLY



--------------------------------------------------------------------------------
4    SOURCE OF FUNDS*

     OO (1)

--------------------------------------------------------------------------------
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]



--------------------------------------------------------------------------------
6    CITIZENSHIP OR PLACE OF ORGANIZATION

     California

--------------------------------------------------------------------------------
               7    SOLE VOTING POWER

  NUMBER OF         -0- shares

   SHARES      _________________________________________________________________
               8    SHARED VOTING POWER
BENEFICIALLY
                    1,166,400 shares (2)
  OWNED BY
               -----------------------------------------------------------------
    EACH       9    SOLE DISPOSITIVE POWER

  REPORTING         -0- shares

   PERSON      _________________________________________________________________
               10   SHARED DISPOSITIVE POWER
    WITH
                    1,166,400 (2)

--------------------------------------------------------------------------------
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,166,400 shares (2)

--------------------------------------------------------------------------------
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

                                                                      [_]

--------------------------------------------------------------------------------
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     47% (2)

--------------------------------------------------------------------------------
14   TYPE OF REPORTING PERSON*

     OO

--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

     (1) Capital contributed by members of New Life Holdings LLC.

     (2)  Includes  1,166,400  shares of common  stock  which are or may  become
issuable to New Life Holdings LLC upon exercise of its warrant.  Of such shares,
116,640 became  exercisable on January 17, 2002,  116,640 became  exercisable on
January  17,  2003,  116,640  become  exercisable  on January  17,  2004 and the
remainder  become  exercisable  on  January  17,  2005.  New Life  Holdings  LLC
disclaims beneficial ownership as to such shares until 60 days prior to the date
upon which its warrant may first




CUSIP No. 69478X105                    13D                    Page 3 of 12 Pages


be exercised as to such shares. The Issuer's Certificate of Incorporation states
that record holders of Common Stock who beneficially own in excess of 10% of the
outstanding shares of Common Stock (the "Limit") are not entitled to any vote in
respect of the shares held in excess of the Limit.




CUSIP No. 69478X105                    13D                    Page 4 of 12 Pages


--------------------------------------------------------------------------------
1    NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     Ezri Namvar

--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a) [_] (b) [X]

--------------------------------------------------------------------------------
3    SEC USE ONLY



--------------------------------------------------------------------------------
4    SOURCE OF FUNDS*

     OO (1)

--------------------------------------------------------------------------------
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]



--------------------------------------------------------------------------------
6    CITIZENSHIP OR PLACE OF ORGANIZATION

     United States

--------------------------------------------------------------------------------
               7    SOLE VOTING POWER

  NUMBER OF         -0- shares

   SHARES      _________________________________________________________________
               8    SHARED VOTING POWER
BENEFICIALLY
                    1,166,400 shares (2)
  OWNED BY
               -----------------------------------------------------------------
    EACH       9    SOLE DISPOSITIVE POWER

  REPORTING         -0- shares

   PERSON      _________________________________________________________________
               10   SHARED DISPOSITIVE POWER
    WITH
                    1,166,400 (2)

--------------------------------------------------------------------------------
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,166,400 shares (2)

--------------------------------------------------------------------------------
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

                                                                      [_]

--------------------------------------------------------------------------------
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     47% (2)

--------------------------------------------------------------------------------
14   TYPE OF REPORTING PERSON*

     IN

--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

     (1) Capital contributed by members of New Life Holdings LLC.

     (2)  Includes  1,166,400  shares of common  stock  which are or may  become
issuable to New Life  Holdings LLC (of which Ezri Namvar serves as Manager) upon
exercise of its warrant.  Of such shares,  116,640 became exercisable on January
17,  2002,  116,640  became  exercisable  on January 17,  2003,  116,640  become
exercisable on January 17, 2004 and the remainder become  exercisable on January
17, 2005. Mr. Namvar disclaims  beneficial  ownership as to such shares until 60
days prior to




CUSIP No. 69478X105                    13D                    Page 5 of 12 Pages


the date upon which its warrant may first be exercised  as to such  shares.  The
Issuer's Certificate of Incorporation states that record holders of Common Stock
who beneficially own in excess of 10% of the outstanding  shares of Common Stock
(the  "Limit")  are not  entitled  to any vote in respect of the shares  held in
excess of the Limit.




CUSIP No. 69478X105                   13D                     Page 6 of 12 Pages


ITEM 1.  SECURITY AND ISSUER

This  statement  relates to the common  stock  (the  "Common  Stock") of Pacific
Premier Bancorp, Inc., f/k/a LIFE Financial Corporation,  a Delaware corporation
(the "Issuer").  The address of the Issuer's principal executive offices is 1600
Sunflower Ave., 2nd Floor, Costa Mesa, California 92626.

ITEM 2.  IDENTITY AND BACKGROUND

         (a) This statement is filed by: (i) New Life Holdings LLC, a California
limited liability company (the "Company"),  with respect to shares  beneficially
owned by it; and (ii) Ezri Namvar,  an individual (the "Manager"),  with respect
to shares  beneficially  owned by him.  The  Manager is the sole  manager of the
Company.

         (b) The  address  of both the  Company  and the  Manager  is 11940  San
Vicente Blvd., Los Angeles, California 90049.

         (c) The Company was formed for the purpose of acquiring, owning, voting
and disposing of the debt and  securities of the Issuer  described  herein.  The
Manager's present  principal  occupation is a private investor - real estate and
lending.

         (d) During the last five years, neither the Company nor the Manager has
been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

         (e) During the last five years, neither the Company nor the Manager has
been a party to a civil  proceeding  of a  judicial  or  administrative  body of
competent jurisdiction and, as a result of such proceeding, was or is subject to
a judgment, decree or final order enjoining future violations of, or prohibiting
or mandating  activities subject to, federal or state securities laws or finding
any violation with respect to such laws.

         (f) The Company is a California limited liability company.  The Manager
is a citizen of the United States.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

         The Company has the right to purchase an aggregate of 1,166,400  shares
of Common  Stock at a price of $0.75 per share upon  exercise of its Warrant (as
defined in Item 4). The aggregate  purchase  price for the Common Stock,  if its
Warrant is exercised in full, is $874,800.  The  Company's  Warrant was acquired
pursuant to a Note and  Warrant  Purchase  Agreement  between the Issuer and the
Company  attached hereto as Exhibit 1. The aggregate  consideration  paid by the
Company  for  both  its  Note  (as  defined  in  Item  4) and  its  Warrant  was
$12,000,000, which was funded with contributions from the Company's members.

ITEM 4.  PURPOSE OF TRANSACTION

         On  November  20, 2001 the Issuer  entered  into an  agreement  for the
private placement of a secured note,  together with a warrant to




CUSIP No. 69478X105                   13D                     Page 7 of 12 Pages


purchase  Common  Stock,  with the  Company  in  exchange  for which the  Issuer
received  $12,000,000.  The sale of the note and warrant was made  pursuant to a
Note and Warrant Purchase  Agreement entered into by the Issuer and the Company.
On January 17, 2002 (the "Closing"), the Issuer issued a Senior Secured Note Due
2007 (the "Note") in the initial  principal  amount of $12,000,000,  and bearing
interest  at an  initial  rate of 12%  (increasing  over  time to 16%),  payable
quarterly  starting  March 31, 2003  (subject to negotiated  prepayment),  and a
warrant  (the  "Warrant")  to purchase up to  1,166,400  shares of the  Issuer's
Common  Stock at an exercise  price of $0.75 per share.  The holders of the Note
have the right to  nominate  three of seven  directors  of the Issuer and of the
Issuer's wholly owned principal operating subsidiary,  Pacific Premier Bank (the
"Bank")  until the later of (i) such time as the Note has been fully  retired or
(ii)  three  years  after  the  Closing.  The  Issuer  pledged  the stock of its
subsidiaries  and a certain  participation  contract  representing  the right to
receive 50% of any cash realized from three residual mortgage-backed  securities
(the "Participation Contract") as collateral against the Note.

         The form of Note and Warrant Purchase  Agreement between the Issuer and
the Company is  attached  hereto as Exhibit 1. Forms of the Note and the Warrant
are attached as Exhibit A and Exhibit B,  respectively,  to the Note and Warrant
Purchase Agreement.

         Upon exercise of the Warrant, which is freely assignable in whole or in
part in  denominations  of not less  than  10,000  shares,  the  Company  or its
assignee(s) (the assignees, together with the Company, the "Warrant Holders" and
each a "Warrant  Holder")  shall  have the right to  purchase  during  specified
periods  a total of up to  1,166,400  shares of Common  Stock.  Pursuant  to the
Warrant,  on or before the first anniversary of the Closing,  the Warrant Holder
will be able to  purchase  116,640  shares  of  Common  Stock.  After  the first
anniversary  of the  Closing,  but on or before  the second  anniversary  of the
Closing,  the Warrant Holder will be able to purchase the initial 116,640 shares
of Common Stock,  plus an additional  116,640 shares of Common Stock.  After the
second anniversary of the Closing, but on or before the third anniversary of the
Closing,  the  Warrant  Holder will be able to  purchase  the 233,280  shares of
Common Stock  available  during the first two years after the  Closing,  plus an
additional  116,640 shares of Common Stock.  After the third  anniversary of the
Closing,  but prior to the tenth anniversary of the Closing (the  "Expiration"),
the Warrant Holder will be able to purchase the 349,920 shares  available during
the first three years after Closing, plus the remaining 816,480 shares of Common
Stock  available  under the Warrant.  Based on 1,333,572  shares  outstanding at
December 31, 2001, if the entire Warrant were exercised,  the shares issued upon
its exercise  would  constitute  approximately  47% of the Issuer's  outstanding
stock.  To date the Company has not  assigned any portion of the Warrant and has
not exercised any portion of the Warrant.

         The Issuer's Certificate of Incorporation  provides that record holders
of Common Stock who beneficially own in excess of 10% of the outstanding  shares
of Common  Stock (the  "Limit")  are not  entitled to any vote in respect of the
shares held in excess of the Limit. A person or entity is deemed to beneficially
own shares  owned by an




CUSIP No. 69478X105                   13D                     Page 8 of 12 Pages


affiliate  of, as well as, by persons  acting in concert  with,  such  person or
entity. The Issuer's Certificate of Incorporation  authorized the Issuer's Board
of Directors to (i) make all determinations necessary to implement and apply the
Limit,  including  determining whether persons or entities are acting in concert
and (ii) to demand that any person who is  reasonably  believed to  beneficially
own stock in excess of the Limit supply  information to the Issuer to enable the
Board of Directors to implement and apply the Limit.

         The Company acquired the Note and the Warrant for investment  purposes.
Any  decision  by the  Company or the  Manager in the future to take any further
actions  with respect to the Issuer or its  securities  will depend upon several
factors,  including  the  prospects of the Issuer,  general  market and economic
conditions and other factors deemed relevant.

         Other than as described above,  neither the Company nor the Manager has
any present plans or proposals that relate to or would result in:

         (a) The  acquisition  by any  person of  additional  securities  of the
Issuer or the disposition of securities of the Issuer;

         (b)  An  extraordinary   corporate  transaction,   such  as  a  merger,
reorganization or liquidation, involving the Issuer or any of its subsidiaries;

         (c) A sale or transfer of a material  amount of assets of the Issuer or
any of its subsidiaries;

         (d) Any change in the present  board of directors or  management of the
Issuer,  including  any  plans or  proposals  to  change  the  number or term of
directors or to fill any existing vacancies on the board;

         (e) Any  material  change in the  present  capitalization  or  dividend
policy of the Issuer;

         (f) Any other  material  change in the  Issuer's  business or corporate
structure;

         (g)   Changes  in  the   Issuer's   charter,   bylaws  or   instruments
corresponding  thereto or other  actions  which may impede  the  acquisition  of
control of the Issuer by any person;

         (h) Causing a class of  securities  of the Issuer to be delisted from a
national  securities  exchange or to cease to be  authorized  to be quoted in an
inter-dealer quotation system of a registered national securities association;

         (i) A class of equity  securities of the Issuer  becoming  eligible for
termination  of  registration  pursuant to Section  12(g)(4)  of the  Securities
Exchange Act of 1934; or

         (j) Any action similar to any of those enumerated above.




CUSIP No. 69478X105                   13D                     Page 9 of 12 Pages


ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER

         (a) As of January 17,  2002,  the Company and the Manager were each the
beneficial owners of 116,640 shares of Common Stock (i.e. those shares of Common
Stock which the  Company had the right to acquire  within 60 days of January 17,
2002).  Based upon  information  available to the Company and the  Manager,  the
Issuer had  approximately  1,333,572  shares of Common Stock  outstanding  as of
January 17, 2002.  Therefore,  the 116,640  shares of Common Stock  beneficially
owned by the  Company  and the  Manager  constituted  approximately  8.0% of the
1,450,212  shares of Common Stock  outstanding  as of January 17,  2002,  giving
effect to the issuance of the 116,640 shares upon exercise of the vested portion
of the Warrant.

         As set  forth  in Item 4 of  this  Schedule  13D,  the  Warrant  may be
exercised as to additional  shares of Common Stock upon each anniversary date of
the Closing, until the third anniversary of the Closing,  following which (until
the  Expiration),  the Warrant  Holder will be able to  purchase  all  remaining
shares of Common Stock  available under the Warrant.  Based on 1,333,572  shares
outstanding at Closing, if the entire Warrant were exercised,  the shares issued
upon its exercise would constitute approximately 47% of the Issuer's outstanding
stock.

         The Company and the Manager disclaim beneficial ownership of any shares
of Common Stock issuable upon exercise of the Warrant until 60 days prior to the
date upon which the Warrant may first be exercised as to such shares.

         (b) Each of the  Company  and the  Manager  share the power to vote and
dispose of all of the  shares of Common  Stock  (including  the shares of Common
Stock which the Company has the right to acquire  upon  exercise of the Warrant)
beneficially owned by it.

         (c) Other than as described in Items 3 and 4 above, neither the Company
nor the Manager have engaged in any  transactions in the Common Stock during the
period  beginning 60 days prior to the date on which the Company and the Manager
acquired beneficial  ownership of more than 5% of the Common Stock of the Issuer
and ending on the date of this Schedule 13D.

         (d) Not applicable.

         (e) Not applicable.


ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
         RESPECT TO SECURITIES OF THE ISSUER

         Except as set forth in Item 4 of this Schedule 13D, neither the Company
nor the  Manager  (other  than as a member of the  Company)  has any  contracts,
arrangements,  understandings  or  relationships  (legal or otherwise)  with any
person with respect to any  securities of the Issuer,  including but not limited
to transfer or voting of any of the securities,  finder's fees,  joint ventures,
loan or option arrangements,




CUSIP No. 69478X105                   13D                    Page 10 of 12 Pages


puts or calls, guarantees of profits, division of profits or loss, the giving or
withholding of proxies.

ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS

         1.  Note  and  Warrant  Purchase  Agreement   (Incorporated  herein  by
reference to the Issuer's  Definitive Proxy Statement for the Special Meeting of
Stockholders  Held  January 10,  2002,  which was filed with the  Commission  on
December 14, 2001).




CUSIP No. 69478X105                   13D                    Page 11 of 12 Pages


                                    SIGNATURE

After  reasonable  inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


                                  July 31, 2003
                                  -----------------------------------
                                  Date

                                  NEW LIFE HOLDINGS LLC,
                                  A California limited liability company


                                  By:      /s/ Ezri Namvar
                                  -----------------------------------
                                  Name: Ezri Namvar
                                  Title: Manager


                                  EZRI NAMVAR

                                           /s/ Ezri Namvar
                                  -----------------------------------
                                  Signature




The  original  statement  shall be signed by each  person  on whose  behalf  the
statement is filed or his authorized representative.  If the statement is signed
on behalf of a person by his authorized  representative (other than an executive
officer  or  general   partner  of  this   filing   person),   evidence  of  the
representative's  authority to sign on behalf of such person shall be filed with
the  statement,  provided,  however,  that a power of attorney  for this purpose
which is already on file with the Commission may be  incorporated  by reference.
The name and any title of each person who signs the statement  shall be typed or
printed beneath his signature.


Attention.  Intentional  misstatements  or omissions of fact constitute  federal
criminal violations (see 18 U.S.C. 1001).




CUSIP No. 69478X105                   13D                    Page 12 of 12 Pages


                                  EXHIBIT INDEX
                                  -------------


         1.  Note  and  Warrant  Purchase  Agreement   (Incorporated  herein  by
reference to the Issuer's  Definitive Proxy Statement for the Special Meeting of
Stockholders  Held  January 10,  2002,  which was filed with the  Commission  on
December 14, 2001).